UPDATE - UBS Initiates Coverage on Ariad Pharma (ARIA) with a Buy; Ponatinib Can Be A Billion Dollar Drug
Go back to UPDATE - UBS Initiates Coverage on Ariad Pharma (ARIA) with a Buy; Ponatinib Can Be A Billion Dollar Drug| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 24.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.82 | 52 Week High | $14.34 | |||
| Open | $24.82 | 52 Week Low | $4.37 | |||
| Day High | $24.82 | P/E | N/A | |||
| Day Low | $24.82 | EPS | $-1.45 | |||
| Volume | 2 | |||||
